| Literature DB >> 25510936 |
Otto R Maarsingh1, Hanneke Stam, Peter M van de Ven, Natasja M van Schoor, Matthew J Ridd, Johannes C van der Wouden.
Abstract
BACKGROUND: The current diagnosis-oriented approach of dizziness does not suit older patients. Often, it is difficult to identify a single underlying cause, and when a diagnosis is made, therapeutic options may be limited. Identification of predictors of dizziness may provide new leads for the management of dizziness in older patients. The aim of the present study was to investigate long-term predictors of regular dizziness in older persons.Entities:
Mesh:
Year: 2014 PMID: 25510936 PMCID: PMC4274723 DOI: 10.1186/1471-2318-14-133
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Figure 1Flowchart with dizziness prevalence at baseline, 7-year follow-up, and 10-year follow-up.
Univariable associations of baseline characteristics (1998/99) with regular dizziness at 7- and 10-year follow-up (2005/06 and 2008/09)
| 7-year follow-up (N = 681) | 10-year follow-up (N = 512) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline characteristic | D+ (N = 129) | D- (N = 552) | OR | 95% CI |
| D+ (N = 73) | D- (N = 439) | OR | 95% CI |
|
|
| ||||||||||
| Age, mean (SD) | 74.0 (6.2) | 72.9 (6.2) | 1.0 | 1.0-1.1 | 0.052 | 72.4 (6.0) | 72.0 (5.9) | 1.0 | 1.0-1.1 | 0.609 |
| Gender, female, n (%) | 99 (76.7) | 304 (55.1) | 2.7 | 1.7-4.2 | <0.001 | 48 (65.8) | 253 (57.6) | 1.4 | 0.8-2.4 | 0.193 |
| Years of education, mean (SD) | 8.3 (2.8) | 9.4 (3.3) | 0.9 | 0.8-1.0 | 0.001 | 9.0 (3.1) | 9.4 (3.3) | 1.0 | 0.9-1.0 | 0.315 |
| Living alone, n(%) | 67 (51.9) | 182 (33.0) | 2.2 | 1.5-3.2 | <0.001 | 36 (49.3) | 144 (32.8) | 2.0 | 1.2-3.3 | 0.007 |
|
| ||||||||||
| Regular dizziness, n (%) | 47 (36.4) | 50 (9.1) | 5.8 | 3.6-9.1 | <0.001 | 28 (38.4) | 41 (9.3) | 6.0 | 3.4-10.7 | <0.001 |
| No. major chronic diseases (0–7), mean (SD) | 1.6 (1.1) | 1.1 (1.0) | 1.4 | 1.2-1.7 | <0.001 | 1.4 (1.1) | 1.1 (1.0) | 1.3 | 1.0-1.5 | 0.015 |
| Chronic pulmonary disease, n (%) | 18 (14.0) | 73 (13.2) | 1.1 | 0.6-1.9 | 0.827 | 9 (12.3) | 58 (13.2) | 0.9 | 0.4-2.0 | 0.836 |
| Cardiac disease, n (%) | 38 (29.5) | 134 (24.3) | 1.3 | 0.9-2.0 | 0.223 | 19 (26.0) | 103 (23.5) | 1.1 | 0.7-2.0 | 0.634 |
| Peripheral arterial disease, n (%) | 14 (10.9) | 33 (6.0) | 1.9 | 1.0-3.7 | 0.053 | 4 (5.5) | 27 (6.2) | 0.9 | 0.3-2.6 | 0.824 |
| Diabetes mellitus, n (%) | 10 (7.8) | 36 (6.5) | 1.2 | 0.6-2.5 | 0.617 | 5 (6.8) | 22 (5.0) | 1.4 | 0.5-3.8 | 0.517 |
| Stroke, n (%) | 5 (3.9) | 26 (4.7) | 0.8 | 0.3-2.2 | 0.683 | 3 (4.1) | 15 (3.4) | 1.2 | 0.3-4.3 | 0.766 |
| Osteo/rheumatoid arthritis, n (%) | 93 (72.1) | 248 (44.9) | 3.2 | 2.1-4.8 | <0.001 | 45 (61.6) | 216 (49.2) | 1.7 | 1.0-2.8 | 0.051 |
| Cancer, n (%) | 25 (19.4) | 58 (10.5) | 2.0 | 1.2-3.4 | 0.006 | 14 (19.2) | 52 (11.8) | 1.8 | 0.9-3.4 | 0.087 |
|
| ||||||||||
| No. of drugs, mean (SD) | 2.9 (2.1) | 2.2 (2.0) | 1.2 | 1.1-1.3 | 0.001 | 2.5 (2.0) | 2.0 (1.9) | 1.1 | 1.0-1.3 | 0.030 |
| Psychopharmaceutical drugs | ||||||||||
| Antidepressants, n (%) | 8 (6.2) | 20 (3.6) | 1.8 | 0.8-4.1 | 0.189 | 2 (2.7) | 16 (3.6) | 0.7 | 0.2-3.3 | 0.698 |
| Anxiolytics, n (%) | 13 (10.1) | 28 (5.1) | 2.1 | 1.1-4.2 | 0.035 | 9 (12.3) | 20 (4.6) | 2.9 | 1.3-6.8 | 0.011 |
| Hypnotics, n (%) | 19 (14.7) | 51 (9.2) | 1.7 | 1.0-3.0 | 0.067 | 8 (11.0) | 37 (8.4) | 1.3 | 0.6-3.0 | 0.481 |
| Cardiovascular drugs | ||||||||||
| Antihypertensives, n (%) | 53 (41.1) | 191 (34.6) | 1.3 | 0.9-2.0 | 0.168 | 32 (43.8) | 147 (33.5) | 1.6 | 0.9-2.6 | 0.086 |
| Diuretics, n (%) | 28 (21.7) | 75 (13.6) | 1.8 | 1.1-2.9 | 0.022 | 12 (16.4) | 49 (11.2) | 1.6 | 0.8-3.1 | 0.201 |
| Nitrates, n (%) | 19 (14.7) | 32 (5.8) | 2.8 | 1.5-5.1 | 0.001 | 9 (12.3) | 27 (6.2) | 2.1 | 1.0-4.8 | 0.061 |
|
| ||||||||||
| Impaired cognition, MMSE ≤24, n (%) | 9 (7.0) | 25 (4.5) | 1.6 | 0.7-3.5 | 0.254 | 4 (5.5) | 15 (3.4) | 1.6 | 0.5-5.1 | 0.392 |
| Anxiety, HADS-A ≥11, n (%)a,f | 17 (13.3) | 17 (3.1) | 4.8 | 2.4-9.7 | <0.001 | 7 (9.6) | 13 (3.0) | 3.5 | 1.4-9.0 | 0.011 |
| Depression, CES-D ≥16, n (%)a,f | 40 (31.3) | 78 (14.2) | 2.8 | 1.8-4.3 | <0.001 | 20 (27.4) | 68 (15.5) | 2.1 | 1.2-3.7 | 0.014 |
| Anxiety or depression a,f | 43 (33.6) | 83 (15.1) | 2.9 | 1.8-4.4 | <0.001 | 21 (28.8) | 72 (16.4) | 2.1 | 1.2-3.6 | 0.013 |
|
| ||||||||||
| Impaired vision, n (%)b | 42 (32.6) | 94 (17.1) | 2.3 | 1.5-3.6 | <0.001 | 20 (27.4) | 71 (16.2) | 2.0 | 1.1-3.5 | 0.022 |
| Impaired hearing, n (%) | 49 (38.0) | 169 (30.6) | 1.4 | 0.9-2.1 | 0.107 | 26 (35.6) | 127 (28.9) | 1.4 | 0.8-2.3 | 0.249 |
|
| ||||||||||
| Impaired function of lower extremities (gait speed), n (%)c,g | 52 (41.3) | 130 (23.8) | 2.3 | 1.5-3.4 | <0.001 | 25 (34.2) | 98 (22.6) | 1.8 | 1.0-3.0 | 0.033 |
| Impaired function of lower extremities (chair stands), n (%)d,h | 65 (51.2) | 146 (26.5) | 2.9 | 2.0-4.3 | <0.001 | 34 (47.2) | 108 (24.7) | 2.7 | 1.6-4.6 | <0.001 |
| Impaired standing balance (tandem stand), n (%)e,g | 35 (27.8) | 97 (17.8) | 1.8 | 1.1-2.8 | 0.012 | 17 (23.3) | 68 (15.7) | 1.6 | 0.9-3.0 | 0.110 |
| Falling past year, n (%)a,f | 46 (35.7) | 159 (28.9) | 1.4 | 0.9-2.0 | 0.134 | 25 (34.2) | 128 (29.2) | 1.3 | 0.7-2.1 | 0.386 |
CI: Confidence Interval; D+: presence of dizziness; D-: absence of dizziness; OR: Odds Ratio.
Missing values at 7-year follow-up in a0.3%, b0.1%, c1.2%, d0.6%, and e1.6% of respondents.
Missing values at 10-year follow-up in f0.2%, g1.0%, and h0.4% of respondents.
Predictors of regular dizziness in an older community population at 7- and 10-year follow-up*
| Characteristic | B | SE | Wald | OR | 95% CI |
|
|---|---|---|---|---|---|---|
|
| ||||||
| Living alone | 0.450 | 0.229 | 3.8 | 1.6 | 1.0-2.5 | 0.050 |
| History of dizziness | 1.324 | 0.265 | 25.0 | 3.8 | 2.2-6.3 | <0.001 |
| History of osteo/rheumatoid arthritis | 0.644 | 0.239 | 7.3 | 1.9 | 1.2-3.0 | 0.007 |
| History of cancer | 0.524 | 0.307 | 2.9 | 1.7 | 0.9-3.1 | 0.088 |
| Use of nitrates | 0.835 | 0.351 | 5.6 | 2.3 | 1.2-4.6 | 0.018 |
| Presence of anxiety or depression | 0.541 | 0.262 | 4.3 | 1.7 | 1.0-2.9 | 0.039 |
| Impaired vision | 0.611 | 0.254 | 5.8 | 1.8 | 1.1-3.0 | 0.016 |
| Impaired function of lower extremities (chair stands) | 0.670 | 0.229 | 8.6 | 2.0 | 1.2-3.1 | 0.003 |
|
| ||||||
| Living alone | 0.460 | 0.278 | 2.7 | 1.6 | 0.9-2.7 | 0.098 |
| History of dizziness | 1.555 | 0.306 | 25.9 | 4.7 | 2.6-8.6 | <0.001 |
| History of cancer | 0.552 | 0.357 | 2.4 | 1.7 | 0.9-3.5 | 0.122 |
| Use of anxiolytics | 0.861 | 0.475 | 3.3 | 2.4 | 0.9-6.0 | 0.070 |
| Impaired function of lower extremities (chair stands) | 0.744 | 0.281 | 7.0 | 2.1 | 1.2-3.7 | 0.008 |
CI: Confidence Interval; OR: Odds Ratio; SE: Standard Error.
*Multivariable logistic regression analysis, using backward elimination (Wald test) with a P value of 0.157 used for removal.
aAUC 0.78 [0.73-0.82], adjusted AUC 0.77 [0.75-0.78], Hosmer-Lemeshow 0.36.
bAUC 0.72 [0.65-0.78], adjusted AUC 0.71 [0.68-0.72], Hosmer-Lemeshow 0.31.